Commit To Buy Affirm Holdings At $35, Earn 18.9% Using Options

A January 2028 $35 put on Affirm (AFRM) is being highlighted as trading with a $6.60 premium, implying a 9.6% annualized return; Affirm shares trade at $58.88, so assignment would require a ~40.6% drop and result in an effective cost basis of $28.40 per share. Trailing 12-month volatility is 75%, underscoring elevated option risk; the position yields income from premium but offers no participation in upside unless assigned, making it a cautious, downside-risk-focused trade idea.

Analysis

Market structure: The quoted Jan‑2028 $35 put on AFRM yielding 9.6% annualized reflects a market pricing of ~40.6% downside to strike from today’s $58.88 and a trailing realized volatility of ~75%. Short‑put sellers collect premium and provide implicit buy‑side liquidity at deep discounts; counterparties (long option holders, retail call buyers) benefit if volatility spikes. Dealers and clearing brokers earn fees and may hedge delta with shares or futures, increasing short-term supply when put selling is heavy.

Risk assessment: Tail risks are regulatory scrutiny of BNPL rules, a sharp consumer credit deterioration, or a capital‑raise that dilutes >20% — any of which could push AFRM below the $28.40 assignment cost (≈‑52% from current). Near term (days–weeks) IV and flows will dominate price; over months the earnings cadence, delinquency data and financing spreads will drive fundamentals. Hidden dependencies include broker margin/assignment mechanics and concentrated put OI at $35 that can create asymmetric liquidity gaps on a crash.

Trade implications: Prefer defined‑risk option structures over naked underwriting: use long-dated call spreads to capture upside and sell limited put spreads (e.g., Jan‑28 35/25 put spread) if willing to own at net ~$30 with capped risk. For relative value, short AFRM vs long PYPL or SQ (size 1–2% NAV) for 3–6 months to play profitability dispersion in payments. Tactical hedge: buy 3–6 month AFRM 40/30 put spread to cap downside at ~15–18% cost of position depending on IV.

Contrarian angles: The market is overpricing one-way assignment risk but underpricing binary recovery catalysts — if AFRM shows sustained revenue growth or narrows loss rates over two consecutive quarters, IV can compress >30pts and call spreads outperform naked puts. Conversely, heavy put selling can crowd the downside and force assignment into illiquid windows; avoid concentrated naked exposure and prefer collars or verticals to monetize premium while limiting forced purchase risk.

Key Decisions for Investors

• If willing to own AFRM, sell Jan‑2028 $35 puts sized to 1% of NAV (max assignment cost $28.40/share). Close or hedge if AFRM ≤ $45 or IV falls below 45% — this limits exposure to a >20% adverse move and preserves capital for assignment.
• Establish a 1–2% long AFRM defined‑risk upside via Jan‑2028 $50/$80 call debit spread (buy $50, sell $80) to participate in multi‑year recovery while capping premium paid; reassess after two quarterly reports.
• Put hedge: buy a 3–6 month AFRM 40/30 put spread for portfolio protection against a >30% downside move, sizing cost to no more than 0.5–1% of NAV; act if IV>60% to get leverage from tail risk.
• Relative value: initiate 1–2% NAV pair trade short AFRM / long PYPL (or long SQ) for 3–6 months to exploit execution and profitability dispersion; tighten if AFRM outperforms by +20% or PYPL/SQ underperforms by >15%.